Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

155 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A Phase III randomized controlled trial of oral dydrogesterone versus intravaginal progesterone gel for luteal phase support in in vitro fertilization (Lotus II): results from the Chinese mainland subpopulation.
Yang DZ, Griesinger G, Wang W, Gong F, Liang X, Zhang H, Sun Y, Kahler E, Pexman-Fieth C, Olofsson JI, Tournaye H, Chen ZJ. Yang DZ, et al. Among authors: griesinger g. Gynecol Endocrinol. 2020 Feb;36(2):175-183. doi: 10.1080/09513590.2019.1645110. Epub 2019 Aug 9. Gynecol Endocrinol. 2020. PMID: 31397179 Clinical Trial.
Ascorbic acid supplement during luteal phase in IVF.
Griesinger G, Franke K, Kinast C, Kutzelnigg A, Riedinger S, Kulin S, Kaali SG, Feichtinger W. Griesinger G, et al. J Assist Reprod Genet. 2002 Apr;19(4):164-8. doi: 10.1023/a:1014837811353. J Assist Reprod Genet. 2002. PMID: 12036083 Free PMC article. Clinical Trial.
A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists.
Kolibianakis EM, Schultze-Mosgau A, Schroer A, van Steirteghem A, Devroey P, Diedrich K, Griesinger G. Kolibianakis EM, et al. Among authors: griesinger g. Hum Reprod. 2005 Oct;20(10):2887-92. doi: 10.1093/humrep/dei150. Epub 2005 Jun 24. Hum Reprod. 2005. PMID: 15979994 Clinical Trial.
155 results